Beth C. Seidenberg - May 18, 2021 Form 4 Insider Report for Vera Therapeutics, Inc. (VERA)

Role: Director
Signature: /s/ Joseph R. Young, Attorney-in-Fact
Stock symbol: VERA
Transactions as of: May 18, 2021
Transactions value $: $0
Form type: 4
Date filed: 5/18/2021, 08:15 PM
Previous filing: May 13, 2021
Next filing: Jun 9, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VERA	Class A Common Stock	Conversion of derivative security		+424K			424K	May 18, 2021	See footnote	F1, F2
transaction	VERA	Class A Common Stock	Conversion of derivative security		+101K	+23.73%		524K	May 18, 2021	See footnote	F3, F4
transaction	VERA	Class A Common Stock	Conversion of derivative security		+819K	+156.24%		1.34M	May 18, 2021	See footnote	F5, F6

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	VERA	Series A Preferred Stock	Conversion of derivative security	$0	-424K	-100%	$0.00^*	0	May 18, 2021	Class A Common Stock	424K		See footnote	F1, F7
transaction	VERA	Series B Preferred Stock	Conversion of derivative security	$0	-101K	-100%	$0.00^*	0	May 18, 2021	Class A Common Stock	101K		See footnote	F3, F8
transaction	VERA	Series C Preferred Stock	Conversion of derivative security	$0	-819K	-100%	$0.00^*	0	May 18, 2021	Class A Common Stock	819K		See footnote	F5, F9

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Series A Preferred Stock automatically converted into Class A Common Stock on a 11.5869:1 basis (on an adjusted basis, after giving effect to the reverse stock split of the Class A Common Stock effected by the Issuer on May 7, 2021) and had no expiration date.
F2	Consists of 409,620 shares of Class A Common Stock held by Kleiner Perkins Caufield & Byers XVI, LLC ("KPCB XVI") and 14,022 shares of Class A Common Stock held by KPCB XVI Founders Fund, LLC ("XVI Founders"). All shares are held for convenience in the name of "KPCB Holdings, Inc., as nominee". The managing member of KPCB XVI is KPCB XVI Associates, LLC ("XVI Associates"). L. John Doerr, Beth Seidenberg, Randy Komisar, Theodore E. Schlein and Wen Hsieh, the managing members of KPCB XVI Associates, exercise shared voting and dispositive control over the shares held by KPCB XVI. Such managing members disclaim beneficial ownership of all shares held by KPCB XVI except to the extent of their pecuniary interest therein.
F3	The Series B Preferred Stock automatically converted into Class A Common Stock on a 11.5869:1 basis (on an adjusted basis, after giving effect to the reverse stock split of the Class A Common Stock effected by the Issuer on May 7, 2021) and had no expiration date.
F4	Consists of 506,819 shares of Class A Common Stock held by KPCB XVI and 17,349 shares of Class A Common Stock held by XVI Founders. All shares are held for convenience in the name of "KPCB Holdings, Inc., as nominee". The managing member of KPCB XVI is XVI Associates. L. John Doerr, Beth Seidenberg, Randy Komisar, Theodore E. Schlein and Wen Hsieh, the managing members of KPCB XVI Associates, exercise shared voting and dispositive control over the shares held by KPCB XVI. Such managing members disclaim beneficial ownership of all shares held by KPCB XVI except to the extent of their pecuniary interest therein.
F5	The Series C Preferred Stock automatically converted into Class A Common Stock on a 11.5869:1 basis (on an adjusted basis, after giving effect to the reverse stock split of the Class A Common Stock effected by the Issuer on May 7, 2021) and had no expiration date.
F6	Consists of 1,298,695 shares of Class A Common Stock held by KPCB XVI and 44,457 shares of Class A Common Stock held by XVI Founders. All shares are held for convenience in the name of "KPCB Holdings, Inc., as nominee". The managing member of KPCB XVI is XVI Associates. L. John Doerr, Beth Seidenberg, Randy Komisar, Theodore E. Schlein and Wen Hsieh, the managing members of KPCB XVI Associates, exercise shared voting and dispositive control over the shares held by KPCB XVI. Such managing members disclaim beneficial ownership of all shares held by KPCB XVI except to the extent of their pecuniary interest therein.
F7	Consisted of 409,620 shares of Class A Common Stock that was automatically converted from the Issuer's Series A Preferred Stock held by KPCB XVI and 14,022 shares of Class A Common Stock that was automatically converted from the Issuer's Series A Preferred Stock held by XVI Founders.
F8	Consisted of 97,199 shares of Class A Common Stock that was automatically converted from the Issuer's Series B Preferred Stock held by KPCB XVI and 3,327 shares of Class A Common Stock that was automatically converted from the Issuer's Series B Preferred Stock held by XVI Founders.
F9	Consisted of 791,876 shares of Class A Common Stock that was automatically converted from the Issuer's Series C Preferred Stock held by KPCB XVI and 27,108 shares of Class A Common Stock that was automatically converted from the Issuer's Series C Preferred Stock held by XVI Founders.